(1S,2R)-Tranylcypromine Hydrochloride (T715000) is used in the preparation of piperidine derivatives, which serve as LSD1 inhibitors for the treatment of cancer.(1S,2R)-Tranylcypromine Hydrochloride (T715000) has been shown to increase monoamine oxidase inhibition andinhibits CYP2A6 with Ki of 0.08 μM and 0.2 μM in cDNVIP(LA)expressing microsomes and Human Liver Microsomes, respectively.